mms prassad koppolu

In his role as Corporate Advisor, Prasad will continue to advise on strategic direction, and optimize growth and scale across all global locations.

Prasad has demonstrated a successful track record of senior leadership in complex, global, customer-focused organizations. He recognizes the strength and value that exceptional talent brings to our business and service functions while applying the best practices from ISO certifications and principles. He also leads infrastructure expansion, supporting the company’s projected growth and driving improved global connectivity.

Diversity is the most powerful force in the world. We all come from different backgrounds, and the differences that we have are used in a positive, unified way to assist sponsors in making the world a better place. Diversity of skills, talent, and experiences is our strength, and we are proud of it.
Prasad M. Koppolu
Corporate Advisor

Prasad has more than 25 years of experience across a diverse group of industries, including technology, transportation, energy, and professional services. He has held senior leadership positions in business development, operations, and research and development, among others.

Prasad earned his master’s degrees in industrial engineering and mechanical engineering from Clarkson University in New York and the Indian Institute of Technology.

Suggested For You

perspectives

November 21st, 2024

Essential Nonclinical Strategies for Cell and Gene Therapy (CGT) Success

news

November 19th, 2024

MMS Recognized as a Top Workplace by Detroit Free Press and USA Today Network for the Fourth Consecutive Year

perspectives

November 12th, 2024

REMS Logic Modeling: Applying FDA Guidance from November 2024 CDER Webinar

news

November 8th, 2024

MMS Named a Finalist in the 2024 Fierce CRO Awards for Leadership in Regulatory Compliance

perspectives

November 6th, 2024

How to Successfully Manage Rescue Studies and Turn Around Clinical Trials Facing Failure

perspectives

October 29th, 2024

Why Outsourcing QC of Regulatory and Medical Writing Documents is a Competitive Advantage for Large Pharma Companies

perspectives

October 22nd, 2024

Choosing the Right Clinical Trial Design: A Crucial Step in Protocol Development

perspectives

October 15th, 2024

Putting the Action in Diversity Action Plans and the Real-Time Data Visualization Technology Needed to Ensure It Happens

news

October 15th, 2024

MMS Recognized with EcoVadis Bronze Medal for Leadership in ESG Sustainability Efforts as a Leading Clinical Research Organization (CRO)

perspectives

October 8th, 2024

Diversity Action Plan Guidance Part I: Implications for Sponsors

webinar

October 22nd, 2024

Optimal Strategies to Protect Commercially Confidential Information (CCI) in Clinical Documents and Report Trial Results Under Revised EU-CTIS Transparency Rules

perspectives

September 30th, 2024

Meet the Leaders Driving MMS’s European Growth